What podcasts say about Eli Lilly and Company
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Eli Lilly and Company
114 statements · 100 positive · 7 negative · 2 mixed · 5 neutral
Eli Lilly will become the world’s largest company
“Eli Lilly will be the biggest company in the world”
Open the episode · Why Is Everything Crashing? | Jordi VisserListen at 25:49
FDA approval requirements give Eli Lilly a competitive moat
“Why does Eli Lilly have a moat? Because you still have to go through the FDA.”
Open the episode · Why Is Everything Crashing? | Jordi VisserListen at 26:52
Investors should avoid chasing Eli Lilly after its recent rise.
“I would be cautious about chasing it here.”
Open the episode · Nvidia Investigation Rocks Stock, Even as Broad Market RalliesListen at 39:47
Eli Lilly is now primarily a GLP-1 drug company rather than diversified pharma.
“This is a GLP-1 story. Absolutely. This is not diversified farmer anymore.”
Open the episode · Our Monthly Portfolio Update - October 2026Listen at 26:31
The Eli Lilly–Hims & Hers agreement should improve discounted medication access.
“the agreement should make it easier for HIMSS customers to get Eli Lilly's weight loss medications. at discounted prices directly through the program.”
Open the episode · Daybreak Weekend: US CPI, Ireland Summit, China's Singles DayListen at 10:55
Eli Lilly holds a strong leadership position in obesity and diabetes markets
“Eli Lilly is sitting in a really strong position, leadership position, when it comes to the obesity market as well as the diabetes market”
Open the episode · Closing Bell Overtime: Markets End a Wild Week With AI Under Pressure 11/6/26Listen at 30:52
Eli Lilly will become the world’s largest company within five years.
“i think eli lily will be the biggest company in the world over the next in the next five years”
Open the episode · Jordi Visser: Is the S&P 500’s Run Over? Where the Next Wealth Boom Is Coming FromListen at 52:28
Investors should initiate a partial position and wait for a decline before adding.
“Buy 25 straight out, and then you wait for a decline.”
Open the episode · Mad Money w/ Jim Cramer 11/3/26Listen at 16:58
- Hari RamachandraPositiveNov 1, 2026· The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network
Eli Lilly leads the obesity-drug market with 60% share, while Novo is second.
“Eli Lilly has taken up 60% of the market share. When Novo is still the second best, but Eli Lilly has the lead now.”
Open the episode · TIP857: S&P Global, Novo, Deckers Brands w/ Stig Brodersen, Tobias Carlisle, & Hari RamachandraListen at 6:39
Eli Lilly revenue is growing 40% year over year
“Eli Lilly's revenue growth year over year is 40%.”
Open the episode · Bitcoin Survives Biggest Crypto Hack In History?! | Jordi VisserListen at 40:40
Eli Lilly will become the world’s largest company within five years
“I've said that I believe in the next five years they will become the biggest company.”
Open the episode · Bitcoin Survives Biggest Crypto Hack In History?! | Jordi VisserListen at 41:55
Eli Lilly could surpass Meta in market capitalization soon
“They could be ahead of Meta soon.”
Open the episode · Bitcoin Survives Biggest Crypto Hack In History?! | Jordi VisserListen at 42:16
Healthcare spending supporting Eli Lilly is guaranteed and non-cyclical
“the spending is coming, is guaranteed every year. It is non-cyclical.”
Open the episode · Bitcoin Survives Biggest Crypto Hack In History?! | Jordi VisserListen at 42:59
Eli Lilly will gain another 30% this year
“this one will be another 30%.”
Open the episode · Bitcoin Survives Biggest Crypto Hack In History?! | Jordi VisserListen at 44:56
Eli Lilly will become the largest AI company relative to Nvidia
“I say this will be the biggest AI company compared to Nvidia”
Open the episode · Bitcoin Survives Biggest Crypto Hack In History?! | Jordi VisserListen at 48:45
Eli Lilly has won the weight-loss drug competition.
“Eli Lilly has clearly won the weight loss drug wars.”
Open the episode · Anthropic’s Growth is Slowing: Is AI Capex Next? | The Weekly WrapListen at 20:30
A Lilly pullback near $1,300 could offer an acceptable entry point.
“close to that $1,300 level is a perfectly palatable entry point here.”
Open the episode · Software Carnage Sparks Nasdaq Sell-Off: Eli Lilly, eBay, Dollar Tree In FocusListen at 15:10
Eli Lilly shares rose 4% after earnings
“Eli Lilly up 4% after reporting earnings”
Open the episode · FOMC semi dovish. Alphabet and ServiceNow crater on earnings.Listen at 15:24
Eli Lilly’s earnings power remains intact.
“Lilly is proving that their earnings power is still intact.”
Open the episode · Software Carnage Sparks Nasdaq Sell-Off: Eli Lilly, eBay, Dollar Tree In FocusListen at 15:31
Eli Lilly is executing well with its weight-loss drugs.
“Eli Lilly still executing well here and doing well with their weight loss drugs.”
Open the episode · Software Carnage Sparks Nasdaq Sell-Off: Eli Lilly, eBay, Dollar Tree In FocusListen at 17:24
Eli Lilly shares rose 6% after beating estimates and raising sales guidance.
“shares of Eli Lilly jumped 6% as the drugmaker beat Wall Street estimates and raised its sales outlook for the year.”
Open the episode · Microsoft Pays Workers to Leave & Google’s Soul SearchListen at 20:55
Eli Lilly is expected to be among the better healthcare performers through 2027 and beyond.
“Lilly comes to mind as probably one of the better performers that we expect looking to not just 3Q, but definitely 2027 and beyond.”
Open the episode · Closing Bell Overtime: Markets Face a Big Week as AI Takes Center Stage 10/26/26Listen at 31:33
Eli Lilly will significantly exceed its ambitious earnings estimates.
“I think it's going to even blow away its incredibly ambitious estimates.”
Open the episode · The $3.5T Bailout: Elon's Plan To Merge Tesla And SpaceXListen at 1:14:43
Eli Lilly has successfully acquired molecules and advanced them to FDA approval.
“companies like Eli Lilly has a great track record of executing on acquiring these kind of companies, acquiring molecules and bringing them through to FDA approval.”
Open the episode · Citrini: Monkeys Are The Next Bottleneck | Citrini on AI Drug Discovery Experiment & Reflexive Financing Risk to AI Buildout & Hardware TradeListen at 55:36
Eli Lilly will benefit from commoditization of phase-one assets.
“that that's a example of a company that is going to benefit from this commoditization of phase one assets.”
Open the episode · Citrini: Monkeys Are The Next Bottleneck | Citrini on AI Drug Discovery Experiment & Reflexive Financing Risk to AI Buildout & Hardware TradeListen at 56:24
Eli Lilly will become America’s largest company within five years.
“will happen within five years.”
Open the episode · Will Bitcoin Survive Quantum Computing? | Jordi VisserListen at 47:40
Eli Lilly is the safest company to own.
“they are the safest company to own.”
Open the episode · Will Bitcoin Survive Quantum Computing? | Jordi VisserListen at 48:52
Eli Lilly’s share price will continue rising and remains a major long position.
“Do I think they will continue to go higher? It's one of my biggest longs. My biggest long, as of right now, is Eli Lilly.”
Open the episode · Will Bitcoin Survive Quantum Computing? | Jordi VisserListen at 48:54
Eli Lilly is the dominant GLP-1 company.
“They are the dominant force as it relates to GLP-1.”
Open the episode · The Bull Market Backdrop in Question: The Investment Committee Weighs in 10/20/26Listen at 20:41
Eli Lilly is the dominant GLP-1 company after beating Novo Nordisk.
“Eli Lilly is the dominant player in JLP1, having now convincingly beaten Novo.”
Open the episode · Dating apps are dying, is Eli Lilly still a buy & Pimp My Portfolio with Owen RaskListen at 18:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.